Nasdaq OMX

Novavax, Inc.

Del

Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., 2015-11-24 22:05 CET (GLOBE NEWSWIRE) --

Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the 27thAnnual Piper Jaffray Healthcare Conference.

Conference details are as follows:

Date: Tuesday, December 1, 2015
Time: 2:00 p.m. U.S. Eastern Time
Location: New York Palace Hotel, New York City
Live webcast:http://edge.media-server.com/m/p/ui3ne8dn

The webcast and a replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website atnovavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company’s website,novavax.com.

Contact:

Novavax,Inc.

BarclayA.Phillips
SVP,ChiefFinancialOfficerandTreasurer

AndreaN.Flynn,Ph.D.
SeniorManager,InvestorRelations

ir@novavax.com
240-268-2000

RussoPartners,LLC

DavidSchull
ToddDavenport,Ph.D.

david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271

Information om Nasdaq OMX

Nasdaq OMX
Nasdaq OMX
Nikolaj Plads 6
1007 København K

+45 3377 0377http://globenewswire.com